GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Purchase Of Business

Notable Labs (Notable Labs) Purchase Of Business : $ Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Purchase Of Business?

Notable Labs's purchase of business for the six months ended in Dec. 2023 was $0.00 Mil. It means Notable Labs spent $0.00 Mil on purchasing business.

Compared with last quarter ($0.00 Mil in Dec. 2022 ), Notable Labs spent the same money on purchasing business in Dec. 2023 ($0.00 Mil).


Notable Labs Purchase Of Business Historical Data

The historical data trend for Notable Labs's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Purchase Of Business Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Purchase Of Business
- - -

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Purchase Of Business - - -

Notable Labs Purchase Of Business Calculation

The amount used to purchase business.


Notable Labs Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Notable Labs's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.